Events

Videos

Podcasts

Articles

Hematologic Oncology

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

The Future of AML Therapy: Cause for Optimism

IDH Inhibitors in AML Therapy

BTK/BCL2 Inhibitors & Other Novel Agents in CLL Therapy

Treatment Options for Relapsed/Refractory AML

Treatment Options for Relapsed/Refractory CLL

Venetoclax-Based Regimens as First-Line Therapy in AML

Venetoclax-Based Regimens as First-Line Therapy in CLL

Glasdegib, Gilteritinib, and Quizartinib Against AML

Venetoclax for CLL After Progression on 1 Prior Therapy

Midostaurin Plus Chemotherapy for FLT3-Mutated AML Cases

Efficacy and Safety of Ibrutinib-Containing Regimens in CLL

Mutational Drivers of Acute Myeloid Leukemia 

Treatment Options for Chronic Lymphocytic Leukemia

Matthew S. Davids, MD, MMSc, associate director, Center for Chronic Lymphocytic Leukemia, Dana-Farber Cancer Institute, discusses updated findings from the DUO study in patients with chronic lymphocytic leukemia.

Dr. Davids Discusses Findings From DUO Study in CLL

Matthew S. Davids, MD, MMSc, discusses the clinical implications of the DUO trial in patients with chronic lymphocytic leukemia.

Crossover to Duvelisib Feasible in Patients With CLL

John F. Seymour, MBBS, PhD, discusses the clinical implications of the MURANO trial and highlights the feasibility for time-limited therapy and its benefits for patients with chronic lymphocytic leukemia.

Time-Limited Therapy With Drug Cessation Feasible in CLL

Standardizing MRD Testing for CLL

Take-Home Messages From ASH 2018 in CLL

CAR T-Cell Therapy for CLL

Duvelisib for Relapsed/Refractory CLL

 Chronic Lymphocytic Leukemia condition center page is a comprehensive resource for clinical news and expert insights on treatment advances and ongoing research in chronic lymphocytic leukemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs and updates with chronic lymphocytic leukemia therapy. 